申请人:Evans David
公开号:US20130102587A1
公开(公告)日:2013-04-25
Disclosed are compounds which inhibit SSAO enzyme activity. Also disclosed are pharmaceutical compositions comprising these compounds and the use of these compounds in the treatment or prevention of medical conditions wherein inhibition of SSAO activity is beneficial, such as inflammatory diseases, immune disorders and the inhibition of tumour growth.
揭示了抑制SSAO酶活性的化合物。还披露了包含这些化合物的药物组合物,以及在治疗或预防抑制SSAO活性有益的医疗状况中使用这些化合物,如炎症性疾病、免疫紊乱和抑制肿瘤生长。